There are moments in investing when clarity cuts through the noise. For me, it started with HIMS. A bold, consumer-first business tackling stigma, expanding access, and building a strong brand in a broken healthcare landscape. I entered when the stock was depressed, when sentiment was exhausted, and when the narrative around DTC medicine was still met w…
